It was announced today that the University of Pennsylvania’s Alzheimer’s Disease Core Center (ADCC) has officially been awarded a five year, $8.8 million renewal from the National Institute on Aging (NIA) at the National Institutes of Health (NIH) to continue investigating the progression, diagnostics, treatments, and strategies of Alzheimer’s disease and related dementias.
“We are hopeful our support for the Penn ADC research program will lead to novel findings on the basic mechanisms involved in these diseases, and innovative new programs aimed at improving the lives of those living with dementia and their caregivers,” explained Nina Silverberg, PhD, an Alzheimer’s Disease Centers program director at NIA, in the Penn Medicine announcement.
The Penn ADCC has a history of groundbreaking discoveries, including identifying the protein tau as the building block of neurofibrillary tangles, as well as the role of alpha-synuclein in forming the Lewy bodies that are found in Parkinson’s disease, Parkinson’s disease dementia, Lewy body dementia, and 50% of Alzheimer’s cases.
Learn more about the Penn ADCC in the video* below:
* Steven Arnold, MD is no longer at the University of Pennsylvania. David A. Wolk, MD is now the Clinical Core leader for the Penn Alzheimer’s Disease Core Center (ADCC).